Open Access
| Numéro |
Med Sci (Paris)
Volume 36, Numéro 10, Octobre 2020
|
|
|---|---|---|
| Page(s) | 844 - 847 | |
| Section | Le Magazine | |
| DOI | https://doi.org/10.1051/medsci/2020151 | |
| Publié en ligne | 7 octobre 2020 | |
- McCormick JB, Webb PA, Krebs JW, et al. A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis 1987 ; 155 : 437–444. [CrossRef] [PubMed] [Google Scholar]
- Kafetzopoulou LE, Pullan ST, Lemey P, et al. Metagenomic sequencing at the epicenter of the Nigeria 2018 Lassa fever outbreak. Science 2019 ; 363 : 74–77. [Google Scholar]
- Baize S, Marianneau P, Loth P, et al. Early and strong immune responses are associated with control of viral replication and recovery in Lassa virus-infected cynomolgus monkeys. J Virol 2009 ; 83 : 5890–5903. [CrossRef] [PubMed] [Google Scholar]
- Geisbert TW, Jones S, Fritz EA, et al. Development of a new vaccine for the prevention of Lassa fever. PLoS Med 2005 ; 2 : 537–545. [Google Scholar]
- Carrion JR, Patterson JL, Johnson C, et al. A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunity. Vaccine 2007 ; 25 : 4093–4102. [CrossRef] [PubMed] [Google Scholar]
- Cashman KA, Wilkinson ER, Shaia CI, et al. A DNA vaccine delivered by dermal electroporation fully protects cynomolgus macaques against Lassa fever. Hum Vacc Immunother 2017 ; 13 : 2902–2911. [CrossRef] [Google Scholar]
- Carnec X, Mateo M, Page A, et al. A vaccine platform against Arenaviruses based on a recombinant hyperattenuated Mopeia virus expressing heterologous glycoproteins. J Virol 2018 ; 92 : e02230–e02217. [CrossRef] [PubMed] [Google Scholar]
- Frantz PN, Teeravechyan S, Tangy F. Measles-derived vaccines to prevent emerging viral diseases. Microb Infect 2018 ; 20 : 493–500. [CrossRef] [Google Scholar]
- Mateo M, Reynard S, Carnec X, et al. Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shot. Sci Transl Med 2019; 11: eaaw3163. [PubMed] [Google Scholar]
- Abreu-Mota T, Hagen KR, Cooper K, et al. Non-neutralizing antibodies elicited by recombinant Lassa-Rabies vaccine are critical for protection against Lassa fever. Nat Commun 2018 ; 9 : 4223. [CrossRef] [PubMed] [Google Scholar]
Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.
Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.
Le chargement des statistiques peut être long.